$EXEL EXELIXIS, INC. Insider Trading Week 39/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in EXELIXIS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in EXELIXIS, INC. in week 39/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Option Exercise | M | 1.90 | 25,000 | 47,500 | 172,698 | |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Option Exercise | M | 1.90 | 2,302 | 4,374 | 197,698 | |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Sell | S | 24.32 | 25,000 | 608,000 | 267,946 | 292.9 K to 267.9 K (-8.53 %) |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Buy | M | 1.90 | 25,000 | 47,500 | 292,946 | 267.9 K to 292.9 K (+9.33 %) |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Sell | S | 23.90 | 2,302 | 55,018 | 267,946 | 270.2 K to 267.9 K (-0.85 %) |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Hessekiel Jeffrey | EVP and General Cou ... | Buy | M | 1.90 | 2,302 | 4,374 | 270,248 | 267.9 K to 270.2 K (+0.86 %) |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Option Exercise | M | 9.91 | 33,334 | 330,340 | 0 | |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Option Exercise | M | 9.91 | 33,333 | 330,330 | 33,334 | |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Option Exercise | M | 9.91 | 33,333 | 330,330 | 66,667 | |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Sell | S | 23.74 | 33,334 | 791,349 | 183,005 | 216.3 K to 183 K (-15.41 %) |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Buy | M | 9.91 | 33,334 | 330,340 | 216,339 | 183 K to 216.3 K (+18.21 %) |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Sell | S | 23.94 | 33,333 | 797,992 | 183,005 | 216.3 K to 183 K (-15.41 %) |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Buy | M | 9.91 | 33,333 | 330,330 | 216,338 | 183 K to 216.3 K (+18.21 %) |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Sell | S | 23.68 | 33,333 | 789,325 | 183,005 | 216.3 K to 183 K (-15.41 %) |
| Sep 28 2017 | EXEL | EXELIXIS, INC. | Schwab Gisela | Pres Prod Dev & Med ... | Buy | M | 9.91 | 33,333 | 330,330 | 216,338 | 183 K to 216.3 K (+18.21 %) |